rs6944446
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022143.5(LRRC4):c.*1216C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.571 in 152,274 control chromosomes in the GnomAD database, including 25,799 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.57 ( 25745 hom., cov: 31)
Exomes 𝑓: 0.47 ( 54 hom. )
Consequence
LRRC4
NM_022143.5 3_prime_UTR
NM_022143.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0250
Publications
7 publications found
Genes affected
LRRC4 (HGNC:15586): (leucine rich repeat containing 4) Predicted to be involved in modulation of chemical synaptic transmission and synapse organization. Predicted to act upstream of or within synapse organization. Predicted to be located in neuron spine and postsynaptic membrane. Predicted to be active in Schaffer collateral - CA1 synapse; glutamatergic synapse; and plasma membrane. Predicted to be integral component of postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2022]
SND1 (HGNC:30646): (staphylococcal nuclease and tudor domain containing 1) This gene encodes a transcriptional co-activator that interacts with the acidic domain of Epstein-Barr virus nuclear antigen 2 (EBNA 2), a transcriptional activator that is required for B-lymphocyte transformation. Other transcription factors that interact with this protein are signal transducers and activators of transcription, STATs. This protein is also thought to be essential for normal cell growth. A similar protein in mammals and other organisms is a component of the RNA-induced silencing complex (RISC). [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.711 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LRRC4 | NM_022143.5 | c.*1216C>T | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000249363.4 | NP_071426.1 | ||
| SND1 | NM_014390.4 | c.1779+36407G>A | intron_variant | Intron 16 of 23 | ENST00000354725.8 | NP_055205.2 | ||
| LRRC4 | XM_011516461.4 | c.*1216C>T | 3_prime_UTR_variant | Exon 3 of 3 | XP_011514763.1 | |||
| LRRC4 | XM_047420695.1 | c.*1216C>T | 3_prime_UTR_variant | Exon 3 of 3 | XP_047276651.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.571 AC: 86673AN: 151722Hom.: 25721 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
86673
AN:
151722
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.472 AC: 206AN: 436Hom.: 54 Cov.: 0 AF XY: 0.485 AC XY: 129AN XY: 266 show subpopulations
GnomAD4 exome
AF:
AC:
206
AN:
436
Hom.:
Cov.:
0
AF XY:
AC XY:
129
AN XY:
266
show subpopulations
African (AFR)
AF:
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
194
AN:
416
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
7
AN:
12
Other (OTH)
AF:
AC:
3
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.571 AC: 86754AN: 151838Hom.: 25745 Cov.: 31 AF XY: 0.565 AC XY: 41894AN XY: 74182 show subpopulations
GnomAD4 genome
AF:
AC:
86754
AN:
151838
Hom.:
Cov.:
31
AF XY:
AC XY:
41894
AN XY:
74182
show subpopulations
African (AFR)
AF:
AC:
29714
AN:
41370
American (AMR)
AF:
AC:
8658
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
1807
AN:
3470
East Asian (EAS)
AF:
AC:
1107
AN:
5152
South Asian (SAS)
AF:
AC:
2613
AN:
4810
European-Finnish (FIN)
AF:
AC:
4955
AN:
10534
Middle Eastern (MID)
AF:
AC:
161
AN:
294
European-Non Finnish (NFE)
AF:
AC:
36093
AN:
67910
Other (OTH)
AF:
AC:
1182
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1821
3641
5462
7282
9103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1438
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.